முறையான இலக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from முறையான இலக்கியம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In முறையான இலக்கியம் Today - Breaking & Trending Today

Internet-based tobacco cessation: Would it work in Covid-19 pandemic?


Photo: Getty Images
By Contributor
7th May 2021
The Covid-19 lockdown has taught us some lessons for Smoking Cessation writes
Prof. Luke Clancy including the use of the Internet. And all those outside smoking areas should never be re-opened after the pandemic
There is a serious need to consider the possible role of internet-based Smoking Cessation services, especially now during the current SARS-CoV-2 COVID-19 pandemic. This is very much in line with national Tobacco Control policy, because despite the Tobacco Free Ireland commitment to a 5% smoking prevalence by the year 2025, Tobacco Free Research Institute’s SimSmoke modelling analysis suggests that this will not happen with the present TFI policies. ....

Khadery Almathami , Allen Carr Easyway , Allen Carr , Luke Clancy , Irish Cancer Society , Tobacco Free Research Institute Simsmoke , Smoking Cessation Services , Health Service , Health Services Executive , World Health Organisation , Smoking Cessation , Tobacco Control , Tobacco Free Ireland , Tobacco Free Research Institute , Smoke Free , Tobacco Products Directive , Medical Officer , Nicotine Replacement Therapy , Nicotine Receptor Agonists , Randomised Control Trials , Stop Smoking , Than Win , Facilitators That Influence Telemedicine Based , Online Consultation , Patient Homes , Systematic Literature ,

Eisai Presents Breadth of Data Across Neurology Portfolio, Including Alzheimer's Disease, Insomnia and Epilepsy


Eisai Presents Breadth of Data Across Neurology Portfolio, Including Alzheimer s Disease, Insomnia and Epilepsy
Twenty-one presentations featuring data and information on investigational lecanemab in early Alzheimer s disease, DAYVIGO® (lemborexant) CIV in insomnia, FYCOMPA® (perampanel) CIII in epilepsy and investigational lorcaserin in Dravet Syndrome
News provided by
Share this article
Share this article
WOODCLIFF LAKE, N.J., April 16, 2021 /PRNewswire/ Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced today that data from the company s deep neurology pipeline and portfolio, including Alzheimer s disease, insomnia and epilepsy, will be presented at the 73
rd Annual Meeting of the American Academy of Neurology (AAN), taking place virtually from April 17-22, 2021. ....

United States , New Jersey , North Carolina , Gary Zammit , Shau Yu Lynch , Alzheimers Dement , Ryan Husni , Genevieve Meier , Carmen Castrillo Viguera , Craig Chepke , Ivan Cheung , Chris Vancheri , Michael Irizarry , Russell Rosenberg , Rakeh Jain , Rohit Shankar , National Institute On , Biogen Inc , Prnewswire Eisai Inc , European Union , Us Drug Enforcement Administration , Eisai Tsukuba Research Laboratories , Meeting Of The American Academy Neurology , National Institutes Of Health , Epilepsy Foundation , Drug Administration ,